X. Rosa Ma,Stephanie D. Conley,Michael Kosicki,Danila Bredikhin,Ran Cui,Steven Tran,Maya U. Sheth,Wei-Lin Qiu,Sijie Chen,Soumya Kundu,Helen Y. Kang,Dulguun Amgalan,Chad J. Munger,Lauren Duan,Katherine Dang,Oriane Matthys Rubio,Shinwan Kany,Siavash Zamirpour,John DePaolo,Arun Padmanabhan,Birth Defects Research Laboratory,Jeffrey Olgin,Scott Damrauer,Robin Andersson,Mingxia Gu,James R. Priest,Thomas Quertermous,Xiaojie Qiu,Marlene Rabinovitch,Axel Visel,Len Pennacchio,Anshul Kundaje,Ian A. Glass,Casey A. Gifford,James P. Pirruccello,William R. Goodyer,Jesse M. Engreitz

Abstract:Congenital heart defects (CHD) arise in part due to inherited genetic variants that alter genes and noncoding regulatory elements in the human genome. These variants are thought to act during fetal development to influence the formation of different heart structures. However, identifying the genes, pathways, and cell types that mediate these effects has been challenging due to the immense diversity of cell types involved in heart development as well as the superimposed complexities of interpreting noncoding sequences. As such, understanding the molecular functions of both noncoding and coding variants remains paramount to our fundamental understanding of cardiac development and CHD. Here, we created a gene regulation map of the healthy human fetal heart across developmental time, and applied it to interpret the functions of variants associated with CHD and quantitative cardiac traits. We collected single-cell multiomic data from 734,000 single cells sampled from 41 fetal hearts spanning post-conception weeks 6 to 22, enabling the construction of gene regulation maps in 90 cardiac cell types and states, including rare populations of cardiac conduction cells. Through an unbiased analysis of all 90 cell types, we find that both rare coding variants associated with CHD and common noncoding variants associated with valve traits converge to affect valvular interstitial cells (VICs). VICs are enriched for high expression of known CHD genes previously identified through mapping of rare coding variants. Eight CHD genes, as well as other genes in similar molecular pathways, are linked to common noncoding variants associated with other valve diseases or traits via enhancers in VICs. In addition, certain common noncoding variants impact enhancers with activities highly specific to particular subanatomic structures in the heart, illuminating how such variants can impact specific aspects of heart structure and function. Together, these results implicate new enhancers, genes, and cell types in the genetic etiology of CHD, identify molecular convergence of common noncoding and rare coding variants on VICs, and suggest a more expansive view of the cell types instrumental in genetic risk for CHD, beyond the working cardiomyocyte. This regulatory map of the human fetal heart will provide a foundational resource for understanding cardiac development, interpreting genetic variants associated with heart disease, and discovering targets for cell-type specific therapies.

A germline chimeric KANK1-DMRT1 transcript derived from a complex structural variant is associated with a congenital heart defect segregating across five generations

Identification of a Likely Pathogenic Structural Variation in the LAMA1 Gene by Bionano Optical Mapping.

A Novel NKX2-5 Mutation in Familial Ventricular Septal Defect.

A Novel Frameshift CHD4 Variant Leading to Sifrim-Hitz-Weiss Syndrome in a Proband with a Subclinical Familial t(17;19) and a Large dup(2)(q14.3q21.1)

A genetic and developmental biological approach for a family with complex congenital heart diseases—evidence of digenic inheritance

Gene editing and cardiac disease modelling for the interpretation of genetic variants of uncertain significance in congenital heart disease

Identification of Candidate Genes for Congenital Heart Defects on Proximal Chromosome 8P

A Novel Nkx2.6 Mutation Associated with Congenital Ventricular Septal Defect

Duplication of 10q22.3–q23.3 encompassing BMPR1A and NGR3 associated with congenital heart disease, microcephaly, and mild intellectual disability

Molecular convergence of risk variants for congenital heart defects leveraging a regulatory map of the human fetal heart

Prenatal detection of novel compound heterozygous variants of the PLD1 gene in a fetus with congenital heart disease

Multiple gene variations contributed to congenital heart disease via GATA family transcriptional regulation

Familial Ventricular Aneurysms and Septal Defects Map to Chromosome 10P15

A Targeted, Next-Generation Genetic Sequencing Study on Tetralogy of Fallot, Combined With Cleft Lip and Palate.

Chromosome Microarray Testing for Patients with Congenital Heart Defects Reveals Novel Disease Causing Loci and High Diagnostic Yield

Whole-exome sequencing identifies a de novo mutation in TRPM 4 involved in pleiotropic ventricular septal defect

Extensive Identification of Genes Involved in Congenital and Structural Heart Disorders and Cardiomyopathy

PCR-sequenced under an ABI PRISM 3130 XL DNA Analyzer ( Applied Biosystems ) with BigDye ® Terminator v 3 . 1 Cycle

A novel homozygous variant of TMEM260 induced cardiac malformation and neurodevelopmental abnormality: case report and literature review

Rare de novo copy number variants in patients with congenital pulmonary atresia.

Functional Analysis of a CHD7 Missense Variant Shows Aberrant RNA Splicing